Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wonder if bottom just speculating, have not followed the company for a while
I see it got deleted and the other one lol. I actually laughed at the the other one because he don't know chit: about the other investment-) always say with this one,when the stock came down %80 over %100 back when he was the other name Lol... don't worry see it before they bring it down before it takes off.....
Just wish they would at least do a simple symptoms trial like this one...as known bucillamine 16x Nac..
Working on writing things up (kept getting interrupted by Greek letter surges…)
— Melisa Lai-becker MD 🇺🇸 (@BostonTox) March 9, 2022
Short summary:
*inpt median Length of Stay: +NAC 5.5 days, -NAC 7.5 days
*outpts later hospitalized: +NAC 2/47, -NAC 8/41 https://t.co/Bnxb2KaKUA
Hello CW. That is all we can do, hope right now. I have been buying back in slowly just to keep my hopes alive at this level. I do believe someday it will make our money back and maybe more, just not as quickly as we had all hoped. Don't know if they are moving to the US.
Thanks for the post, Gator. I haven't seen these threads. It seems like nobody is a believer anymore. Anyway, like the fellow before me stated, we wait for a small miracle.
hope the schroom business (or Long Covid treatment) can get this company back on track..surprised BUCI hasn't been approved since it's been used in ASIA for many years without many complications...OR a BIG Pharma company would've bought that portion off RVVTF by now....need a minor miracle get back to .25 cents or more ...let's go MF
NEWS: Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder
https://ceo.ca/@GlobeNewswire/revive-therapeutics-provides-update-on-psilocybin-clinical-b2e9a
Yup. Just have my shares for a wing and a prayer, but I've accepted my loss and will be working two more years to pay for it. If something develops, I'll be pleasantly surprised.
ps. Is Revive still moving to the U.S.A?
pps. New blackjack analogy. We have a solid 16 and the dealer has an ace. This assumes we still have a chip to play with- It's been a disaster of a run.
ppps. All good. Life goes on..........................
agreed, I sold off a great amount of my shares to take the loss EOY but still have shares left just in case something happens. I lost patience with this company at least 6 months ago.
How.much longer lol. Damn I spent about 3 years trying dd here lol...ah well they already mislead investors around 18 months like they might have symptoms data lol.... about 18 months after trial failed. And I know now none was respected from people still here which has me Lmao......
No money no honey. Fact...this fraud of a company is underwater financially. All the enabling and delusion of this scam will not change that fact. It's a dog and pony show.
Thanks for sharing, Shelby. The ball is rolling again..... or at least moving like a turtle.... but moving nonetheless.
Already on to EMGE. Thank you PB!!!
BTW. Let's go RVVTF$
Thanks Rubber where you been lol
I know easily can talk to u on your stockwits..
But another 6 shots and wondering how to reply better lol....
This is another long covid trial which😄 I wish some how rvvtf can get the funding like this...
@WesElyMD launching his #LongCovid clinical trial this Spring to test Baricitinib — a JAK inhibitor with broad immunomodulatory properties. 550 people.
— charlos (@loscharlos) January 11, 2024
The funding came from NIH — not from RECOVER — but from National Institute of Aging. https://t.co/C2vVSsguFZ
You're not a nobody Gatorca. I remember multiple outstanding DD's from you back in the hopeful days of RVVTF$
Lol nothing compares to the idiots bashers in 1 other stocks I have still trying to get some losses I had here Cw
hasn't gone good to be honest,but maybe found the right one now....emge. if some veterans from ihub is right.... :)..
So maybe buy back more . But see possibility of 5 to 10x from here . But am a nobody here in ihub which I'm ok with lol..
Ps. Some already long covid drugs being trial WeslyMd is one..hope things turn out good eventually even if I didn't buy back in:)
Pss. Hopefully Cw and other longs at.least make the money back...6 shots kicks in...lol
just checking in today... There is money to be made in the long covid arena. The question is can MF capitalize on it? Your guess is as good as mine.
ps. an even longer shot is Bucy as a biowarfare agent. Whatever at this point. Just hoping to make some money back or get close at some point. I'm not in a rush anymore.
LOL once again. Buzz off, Skid Marker. 💩
Isn't a little late to the party for Covid ..also did the company ever make their move to New Jersey to be near JNJ...also where are the revs coming from other than dilution/ toxic notes...hope things work out as promised but still very skeptical at best...just my two cents..
The stock market rips to an all time high and what happens to Revive? Zero...a big fat zero even with all this so-called "news". It's the same pump routine you guys swallowed hook, line, and sinker the last time. Scam & Fraud 2.0 is underway. This company is finished. Stick a fork in it.
Excellent news and an example of what us Longs wanted for Bucillamine's additional use cases. Thanks for posting this.
News: Revive Therapeutics To Submit Type C Meeting Request with FDA for Bucillamine to Treat Long COVID
March 19, 2024
https://www.globenewswire.com/en/news-release/2024/03/19/2848420/0/en/Revive-Therapeutics-To-Submit-Type-C-Meeting-Request-with-FDA-for-Bucillamine-to-Treat-Long-COVID.html
So he spent about $11,500. Big deal! That's not an investment. At 2 cents per share, that's simply pocket change! Does very little, for my confidence at least.
Nice to see Mr Frank purchasing on the open market. 576000 shares total.
Whats up RVVTF board,havent checked in for a while good to still see some old names. Still holding all my shares and crossing fingers that we will at some point in time see some movement,hope everyone has a great week.
News out. Still waiting for phase 2 trial. Ugh. Let the debbie downers comment galore.
https://www.globenewswire.com/news-release/2024/03/12/2844382/0/en/Revive-Therapeutics-Provides-Corporate-Update.html
He buried treasure in the Bahamas for his golf and hooker boon goggle. PPS says it all.
Not at all mate.
Let the like "speak" so the world sees them for what they truly are.
Feb 28 MD&A says it all. End of year only about $708,000 cash on hand and $3.1 million in accounts payable and liabilities. Even if you add in the $2 million from the offering this isn't rocket science, it's simple math. Maybe some of these guys think MF has a money tree in his back yard.
He also should be kicked off the site for that comment
Not at all surprised that comment came from the board poofter!
That’s so absurd people still throwing cash at this trash lol
It looks very promising but in all honesty its about time Revive/MF starts closing on one or more of these targets.
An effective/accurate LC test would be huge IMO but I think i'll hold off on the "celebrations" for the time being.
I'm pretty sure you are the second of 8,000,000,000 to see this news. Thanks for sharing. MF beat you to it.
Has anyone else seen this?
Product: Diagnostic Rapid Test
Indication: Long COVID
Stage of Development: Pre-commercial prototype
Regulatory Status: Preparing submission for FDA approval pathway
https://revivethera.com/wp-content/uploads/2024/02/RVV-Deck-February-2024a.pdf
NEWS: Revive Therapeutics Ltd. Announces Closing of the Second and Final Tranche of Its Private Placement for Gross Proceeds of $1,187,110
https://ceo.ca/@GlobeNewswire/revive-therapeutics-ltd-announces-closing-of-the-second
Literally EVERY SINGLE Biotech does exactly that ye gobshite.
Cash is raised based on the potential of the drug/treatment being effective as opposed to being a surety.
Seems you started trading biotechs last week based on the absolutely foolish arguments constantly being made.
There is a strong argument that the purpose of testing is to produce hope, faith, and excitement in order to keep the cash rolling into MF's pocket. This is a cash cow for him and he has all the motivation in the world to milk it as long as he can. You can't tell me this hasn't happened before with penny stock biotechs. In fact it probably happens more often than not with 2 cent biotechs. It's textbook and MF has the perfect motive for doing this....30k per month of shareholder money automatically sent to his bank account. What reason does he have to stop? The longer he strings investors along the more money goes into his pocket...right? It's not rocket science. What has he produced in 4 years? Nothing...absolutely nothing, but how much of your money has he socked away? The writing was on the wall a long time ago and I think most of you see it but just want your money back which is fair, but I question MF's desire to do anything except keep the ball rolling straight to his bank account. That's the only thing he has ever accomplished and it's worked for him. Hence bucillamine 2.0, and he'll keep doing it until the money stops.
Saying "IF" indicates that the company is working on projects like every other Biotech does.
The buccy defense testing and the micro needle patch collaboration are just two examples of said possibilities....not once have I ever indicated that anything was guaranteed hence my continuous usage of "IF".
If Revive had nothing as you claim then there would be no purpose for the testing on the behalf of these external entities eejit.
That said please do regale us some more with this fine display of grammatical idiocy!!!
Yeah. Playing mind games with yourself is not an investment strategy, it's sunk cost fallacy at its fullest.
Yes. Peeps like ric talking themselves into overpaying for an offering. It’s better then being wrong
IF MF can finally finalize some type of deal
could bear fruit at some point.
that sector is still in its infancy
It now all rests on MF being able to finally execute
Nothing....all you got is a bunch of "ifs". Let me spell it out for you Z-E-R-O.
This has been going on nonstop for 4 years now. Where has it gotten the shareholders?
Amazing they are able to raise funds at a premium to market price. Thank goodness only Canadians can get that kind of deal lol
Revive has nothing. You're both right.
Go play yer simple minded word games with your mental midget friends eejit.
I agreed with ye. I said you were right. I thought we kind of bonded on this one.
If thats your assessment of my post then I suggest you go back to school and learn how to read and comprehend what ye read.
Hmmm...it seems to me that Snoop dog said pretty much the same thing you did in your next post. He was just more to the point and did it in a fraction of the words that you did. Revive has nothing. You're both right.
Formalizing the merger would be a solid for Revive……AIMHO
Yes follow. They’re making some solid strides lately. Looking for more solid positioning Q2.
Followers
|
339
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
36627
|
Created
|
02/23/17
|
Type
|
Free
|
Moderators Classic Warrior |
Scientific Rationale of Bucillamine
Preclinical and clinical studies have demonstrated that reactive oxygen species contribute to the destruction and programmed cell death of pulmonary epithelial cells.1 N-acetyl-cysteine (NAC) has been shown to significantly attenuate clinical symptoms in respiratory viral infections in animals and humans, primarily via donation of thiols to restore antioxidant and to reduce the activity of cellular glutathione 2,3,4,5. Bucillamine (N-(mercapto-2-methylpropionyl)-l-cysteine) has a well-known safety profile and is prescribed in the treatment of rheumatoid arthritis in Japan and South Korea for over 30 years. Bucillamine, a cysteine derivative with two thiol groups, has been shown to be 16 times more potent as a thiol donor in vivo than NAC 6. The drug is non-toxic with high cellular permeability. The basis of the clinical study will analyze if Bucillamine has the potential, via restoration of glutathione activity and other anti-inflammatory activity, to lessen the negative consequences of SARS-CoV2 infection in the lungs.
| Psilocin Pharma Corp. has developed production solutions for the active compound Psilocybin. Our process encompassed with our intellectual property cover methods of production of Psilocybin based formulations. Psilocin Pharma Corp’s range of products have been engineered to work synergistically with the body's own natural pathways of absorption while offering a contemporary approach to consumption. Psilocin Pharma also has strong relationships with specific lab partners in certain areas like Brazil, where these formulations are legally approved and plan to sell products in these jurisdictions. | |
| |
Mental Health (Depression, PTSD & Anxiety)
|
Supplements for Brain Health & Cognitive Enhancement
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |